voriconazol teva 20 mg
teva pharmaceuticals s.r.l. - voriconazolum - pulb. pt. sol. perf. - 200mg - antimicotice de uz sistemic derivati de triazol
avinew, vaccin aviar
merial, franța - virusul - vaccin liofilizat - păsări
sulfat de magneziu-darnita solutie injectabila 250 mg/ml
darnita sap, firma farmaceutica - magneziu sulfas - solutie injectabila - 250 mg/ml
sulfat de magneziu-darnita solutie injectabila 250 mg/ml
darnita sap, firma farmaceutica - magneziu sulfas - solutie injectabila - 250 mg/ml
bioral h 120, vaccin
merial, franța - virus - vaccin liofilizat - pui de găină
imopest, vaccin aviar
merial, franța - virusul - vaccin inactivat - păsări
naxcel 100mg/ml, emulsie injectabilă
zoetis belgium sa, sua - ceftiofur - emulsie injectabilă
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
ketorolac rompharm solutie injectabila 30 mg/ml
rompharm company srl, sc - ketorolacum tromethaminum - solutie injectabila - 30 mg/ml
ketoprofen rompharm solutie injectabila 50 mg/ml
rompharm company srl, sc - ketoprofenum - solutie injectabila - 50 mg/ml